Have been monitoring for a few weeks now and seems got support at 34 to 35. Banking on the low days being over soon. just entered a small position here.
Hello, sharing this great video by StockCharts TV, one of my favourite channels on Youtube. As Growth and Tech stocks struggles now, here is 10 stock ideas you can consider from the great team at StockCharts TV. The theme is clear, Energy, Metals, Industrial. I am definitely looking at this closely. Do have your own trading plan, this list DOES NOT mean a BUY NOW. As the market is still choppy and going through some speed bumps and recalibration, do yo...
Yeti's Q4 earnings report and cautious guidance resulted in a stock slump. Despite missing EPS estimates and a below consensus full-year EPS forecast, the company eyes growth through brand, product, and geographic expansion.
The market's high opinion of the business is reflected in its high P/E ratio of 61.92. Despite a recent drop, long-term returns look promising, indicating the share price may be pausing while the business focuses on growth strategy.
Despite a low ROE, YETI Holdings' net income growth indicates other factors like efficient management or low payout ratio may be positively impacting earnings growth. Analysts forecast an acceleration in the company's earnings.
The downward trend in ROCE for YETI Holdings does not inspire much confidence for its potential as a multi-bagger. Despite the company's reinvestment strategies, if the underlying trends continue, its future prospects remain uncertain.
Pre-Market Stock Movers Gapping up $阿斯利康(AZN.US)$ (Shares of the British pharmaceutical company gained more than 2.7% in premarket trading after the company reported positive results for its drug Dato-DXd in a trial for treating a common type of breast cancer.) $Wayfair(W.US)$ (Shares gained more than 2% after Bernstein upgraded home merchandiser to market perform from underperform. The firm cited improving revenue gr...
$ASTRAZENECA PLC(AZNCF.US)$ — Shares of the British pharmaceutical company gained more$Wayfair(W.US)$than 2.7% in premarket trading after the company reported positive results for its drug Dato-DXd in a trial for treating a common type of breast cancer. $Wayfair(W.US)$ — Shares gained more than 2% after Bernstein upgraded home merchandiser to market perform from underperform. The firm cited improving revenue growth and margin commentary. Chinese e-commer...
YETI Holdings股票讨论区
As Growth and Tech stocks struggles now, here is 10 stock ideas you can consider from the great team at StockCharts TV. The theme is clear, Energy, Metals, Industrial. I am definitely looking at this closely. Do have your own trading plan, this list DOES NOT mean a BUY NOW. As the market is still choppy and going through some speed bumps and recalibration, do yo...
$YETI Holdings(YETI.US)$
📊⚡️📊
Gapping up
$阿斯利康(AZN.US)$
(Shares of the British pharmaceutical company gained more than 2.7% in premarket trading after the company reported positive results for its drug Dato-DXd in a trial for treating a common type of breast cancer.)
$Wayfair(W.US)$
(Shares gained more than 2% after Bernstein upgraded home merchandiser to market perform from underperform. The firm cited improving revenue gr...
— Shares of the British pharmaceutical company gained more $Wayfair(W.US)$ than 2.7% in premarket trading after the company reported positive results for its drug Dato-DXd in a trial for treating a common type of breast cancer.
$Wayfair(W.US)$
— Shares gained more than 2% after Bernstein upgraded home merchandiser to market perform from underperform. The firm cited improving revenue growth and margin commentary.
Chinese e-commer...
目前市盈率40,即使按2021年2.1亿近期净利高点计算,市盈率也达到了17,估值没有吸引力。
暂无评论